Longeveron LGVN
NASDAQ LGVN
$3.21 -0.09 (-2.73%)
As of: Nov 12, 2026 · 9:30 AM EST

Longeveron (LGVN) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Longeveron's Return on Capital Employed [ROCE] was -168.46% in Q2 2026, down 42.72 percentage points from -125.74% a year earlier but up 32.41 percentage points from the prior quarter.

Analysis

Longeveron (LGVN) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Longeveron came in at -168.47%, down 66.71 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a three-year change of -108.77 percentage points (FY2022 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -101.76% in FY2024 (+30.86 pp), -132.62% in FY2023 (-72.92 pp) and -59.70% in FY2022.
  • Quarterly Return on Capital Employed [ROCE] has moved between -364.83% (Q1 2024) and -65.68% (Q4 2024) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has declined for four straight quarters, with an average year-over-year change of +18.55 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2025 (a gain of 278.83 percentage points); the worst was Q1 2024 (a drop of 272.68 percentage points).
  • Per Business Quant data, LGVN's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -200.88% (Q1 2026), -263.97% (Q4 2025) and -197.71% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Longeveron 8.60 Mn -31.21 Mn 182,000.00 -168.46%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -168.46%
Mar 31, 2026 -200.88%
Dec 31, 2025 -263.97%
Sep 30, 2025 -197.71%
Jun 30, 2025 -125.74%
Mar 31, 2025 -86.00%
Dec 31, 2024 -65.68%
Sep 30, 2024 -82.03%
Jun 30, 2024 -160.49%
Mar 31, 2024 -364.83%
Dec 31, 2023 -264.10%
Sep 30, 2023 -189.97%
Jun 30, 2023 -135.71%
Mar 31, 2023 -92.15%
Dec 31, 2022 -74.88%
Sep 30, 2022 -57.64%
Jun 30, 2022 -49.22%
Mar 31, 2022 -45.10%
Dec 31, 2021 -54.13%
Sep 30, 2021 -55.73%
API Access

Longeveron Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LGVN&period=max&api_key=YOUR_API_KEY